Scorpion Venom Peptides in Oncology (MDA-MB-231), Gold Nanoparticle (AuNP) Biosensors & Antimicrobial Drug Discovery
How bioactive peptides from Androctonus crassicauda and Androctonus turkiyensis drive breakthroughs across oncology, nanobiotechnology (AuNP biosensors), targeted drug delivery, and antibiotic-resistant pathogens.
1. Selective Apoptosis in Breast Cancer (MDA-MB-231) and Glioma Cell Lines
Preclinical oncology studies demonstrate that Androctonus crassicauda venom peptides induce selective cytotoxicity in triple-negative breast cancer (MDA-MB-231) and glioma lines by disrupting mitochondrial membrane potential and activating intrinsic apoptosis pathways.
2. Gold Nanoparticle (AuNP) Conjugation, Biosensors & Carrier Vectors
Conjugating scorpion venom peptides with Gold Nanoparticles (AuNP) enhances bioavailability and enables high-sensitivity electrochemical biosensor architectures as well as receptor-targeted drug delivery vectors.
3. Antimicrobial Activity Against E. coli and S. aureus
Cationic venom peptides directly permeabilize the lipid bilayers of Gram-negative (E. coli) and Gram-positive (S. aureus) bacteria, offering novel templates against multidrug-resistant (MDR) infections. Request research-grade venom batches from TURKIYENSIS.